Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LUCD Lucid Diagnostics > Detailed Quotes

LUCD Lucid Diagnostics

Watchlist
1.270
-0.030-2.31%
Trading Session  02/08 12:06 ET
High
1.310
Open
1.290
Turnover
25.46K
Low
1.270
Pre Close
1.300
Volume
19.70K
Market Cap
49.67M
P/E(TTM)
Loss
52wk High
4.060
Shares
39.11M
P/E(Static)
Loss
52wk Low
1.105
Float Cap
7.20M
Bid/Ask %
92.31%
Historical High
13.520
Shs Float
5.67M
Volume Ratio
0.77
Historical Low
1.105
Dividend TTM
--
Div Yield TTM
--
P/B
1.80
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.35%
Amplitude
3.08%
Avg Price
1.292
Lot Size
1
Float Cap
7.20M
Bid/Ask %
92.31%
Historical High
13.520
Shs Float
5.67M
Volume Ratio
0.77
Historical Low
1.105
Dividend TTM
--
P/B
1.80
Dividend LFY
--
Turnover Ratio
0.35%
Amplitude
3.08%
Avg Price
1.292
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Lucid Diagnostics, Inc. develops medical testing devices. It is a commercial-stage medical diagnostics technology company which focuses on gastroesophageal reflux disease (GERD), acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma (EAC). The firm's products include EsoCheck is a cell collection device that is designed to collect cells of a targeted region of the esophagus without the need for endoscopy and EsoGuard is a laboratory developed test which analyzes methylated biomarkers. The company was founded on May 8, 2018 and is headquartered in New York, NY.
CEO: Dr. Lishan Aklog, M.D.
Market: NASDAQ
Listing Date: 10/14/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist